Camber Pharmaceuticals, Inc 2022-12-21 Health moderate FDA
Health · FDA · Recall #FDA-D-0094-2023
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only,… Recall
Issued December 21, 2022 · Camber Pharmaceuticals, Inc
In December 2022, Camber Pharmaceuticals, Inc recalled the Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only,…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
What you should do
- 1 Stop using Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Camber Pharmaceuticals, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Camber Pharmaceuticals, Inc
- Category
- Health
- Recall date
- December 21, 2022
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0094-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Camber Pharmaceuticals, Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.